Welcome to our dedicated page for Kosmos Energy SEC filings (Ticker: KOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking proved reserves, production sharing contracts, and offshore lease commitments across Kosmos Energy’s deep-water portfolio can mean combing through hundreds of pages of technical disclosures. If you have ever searched “What does Kosmos Energy report in their SEC filings?” or struggled to locate a single table in a 300-page 10-K, you know the challenge.
Stock Titan solves it. Our AI reads every Kosmos Energy quarterly earnings report 10-Q filing, Kosmos Energy annual report 10-K simplified, and Kosmos Energy 8-K material events explained the moment they hit EDGAR, then serves plain-English highlights of reserves revisions, Tortue LNG milestones, hedging gains, and environmental liabilities. Need real-time alerts? We push Kosmos Energy Form 4 insider transactions real-time so you can monitor executive drilling before you drill down into the numbers yourself.
Here’s what investors uncover faster with our platform:
- Production trends and capex plans distilled from 10-K/10-Q—Kosmos Energy SEC filings explained simply
- Immediate notifications of Kosmos Energy insider trading Form 4 transactions and Kosmos Energy executive stock transactions Form 4
- Board pay policies inside the Kosmos Energy proxy statement executive compensation
- Discovery updates and FPSO outages flagged in 8-Ks
- Concise Kosmos Energy earnings report filing analysis with quarter-over-quarter metrics
- Guided walkthroughs for understanding Kosmos Energy SEC documents with AI
Whether you’re comparing Jubilee output across quarters or assessing cash flows for Tortue Phase 1, our AI-powered summaries, expert commentary, and real-time feeds turn regulatory complexity into actionable clarity—without downloading a single spreadsheet.
BlackRock Portfolio Management LLC filed Amendment No. 1 to Schedule 13G for Stoke Therapeutics, Inc. (STOK) dated 30 June 2025. The filing discloses that BlackRock’s reporting business units now beneficially own 2,550,341 common shares, representing 4.7 % of outstanding stock. Because the position is < 5 %, the firm is reporting under Rule 13d-1(b) as a passive institutional investor.
The shares are held with sole voting power over 2,412,388 shares and sole dispositive power over the full 2,550,341 shares; there is no shared voting or dispositive authority. BlackRock confirms the shares are held in the ordinary course of business and not for the purpose of influencing control of the issuer. Item 5 expressly states that BlackRock’s ownership has fallen to 5 % or less of the class, triggering the amended filing.
While BlackRock remains a meaningful holder, the reduction below the 5 % threshold removes it from the list of “5 % owners” in future proxy statements and may slightly reduce perceived institutional sponsorship. No other financial metrics, transactions, or strategic actions are disclosed in this filing.